← FDA Drug Approvals (Drugs@FDA)
IMIPENEM AND CILASTATIN
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ACS DOBFAR · Approved 2011-12-21
Drug application
- FDA Application #
ANDA090577- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- IMIPENEM AND CILASTATIN
- Generic name
- IMIPENEM AND CILASTATIN SODIUM
- Active ingredients
- CILASTATIN SODIUM; IMIPENEM
- Dosage form
- POWDER
- Route
- INTRAVENOUS
- Marketing status
- Prescription
- Sponsor
- ACS DOBFAR
- Manufacturer
- Fresenius Kabi USA, LLC
- First approval
- 2011-12-21
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown